Qiagen ramps up molecular Dx offering with ESE buy
This article was originally published in Clinica
Executive Summary
Qiagen has bolstered its leadership in the field of molecular sample and assay technologies by acquiring ESE, a German firm specialising in UV and fluorescence optical measurement devices.